Transforming growth factor β1 (TGFβ1) down-regulates expression and function of proliferation-inducing molecules in HPV-transformed cells

Anticancer Research

Volumn 19, Issue 6 B, 1999, Pages 4977-4982

  Shier, Medhat K ^a   Neely, Elizabeth B ^a   Ward, Margaret G ^a   Meyers, Craig ^a   Howett, Mary K ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Differentiation; HPV; TGF 1

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 2; PROTEIN C JUN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEWBORN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS CELL TRANSFORMATION; VIRUS STRAIN; WART VIRUS;

BASE SEQUENCE; CELL DIVISION; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; DNA PRIMERS; DOWN-REGULATION; HUMANS; PAPILLOMAVIRIDAE; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-JUN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 0033391233     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Parkin DM, Pisani P and Ferlay J: Estimates of the world wide incidence of eighteen major cancers in 1985. Int J Cancer 54: 594-606, 1993.
2. Xi L.F. and Koutsky L.A: Epidemiology of genital human papillomavirus infections. Bull Inst Pasteur 95: 161-78, 1997.
3. Dillner J: Can cervical cancer screening programs be improved by incorporating screening for human papillomavirus infection? Cancer J 11: 272-276, 1998.
4. Schlegel R: Papillomaviruses and human cancers. Sem Virol 1: 297-306, 1990.
5. Laimins L. A: The biology of human papillomaviruses: From warts to cancer. Infectious Agents and Disease 2: 74-86, 1993.
6. Delius H, Saegling B, Bergmann K, Shamanin V and DeVilliers E.-M: The genomes of three of four novel HPV types, defined by differences of their L1 genes, show high conservation of the E7 gene and the URR. Virol 240: 359-65, 1998.
7. DeVilliers EM: Heterogeneity of the human papillomavirus group. J Virol 63: 4898-903, 1989.
8. DeVilliers E.-M: Human pathogenic papillomavirus types: an update. In: H. Zur Hausen (ed.), Human Pathogenic Papillomaviruses, pp. 1-12. Berlin: Springer, 1994.
9. Zur Hausen H: Human papillomaviruses in the pathogenesis of anogenital cancer. Virol 184: 9-13, 1991.
10. Zur Hausen H: Papillomavirus infections - a major cause of human cancers. Biochem. Biophys. Acta 1288: F55-78, 1996.
11. Shier MK, Neely EB, Ward, MG, Richards ME, Manders EC, Meyers C and Howett MK: Correlation of overexpression of transforming growth factor β1 (TGFβ1) with the down-regulation of proliferation-inducing molecules in HPV-11 transformed human tissue xenografts. Submitted, 1999.
12. Rader JS, Golub TR, Hudson JB, Patel D, Bedell MA and Laimins LA: In vitro differentiation of epithelial cells from cervical neoplasias resembles in vivo lesions. Oncogene 5: 571-6, 1990.
13. Arsura M, Wu M and Sonenshein GE: TGFβ1 inhibits NFkB/Rel activity inducing apoptosis of B cells: transcriptionalactivation of INB-α. Immunity 5: 31-40, 1996.
14. Tsakada T, Eguchi K, Migita K, Kawabe Y, Kawakami A, Matsouka N, Takashima H, Mizokami A. and Nagataki S: Transforming growth factor beta 1 induces apoptotic cell death in cultured human umbilical vein endothelial cells with down-regulated expression of bcl-2. Biochem Biophys Res Commun 210: 1076-82, 1995.
15. Lohman F, Gibbs S, Fischer D, Borgstein A-M, Putte P and Backendorf C: Involvement of c-jun in the regulation of terminal differentiation genes in normal and malignant keratinocytes. Oncogene 14: 1823-7, 1997.
16. Pietenpol J, Holt J, Stein R, and Moses H: Transforming growth factor beta 1 suppression of c-myc gene transcription: Role in inhibition of keratinocyte proliferation. Proc Natl Acad Sci USA 87: 3758-62, 1990.
17. Meyers C: Organotypic (raft) epithelial tissue culture system for the differentiation-dependent replication of papillomavirus. Meth Cell Sci 18: 201-10, 1996.
18. Beg AA, Ruben SM, Haskil S, Rosen CA and Baldwin ASJr: I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention. Genes Dev 6: 1899-913, 1992.
19. May MJ and Ghosh S: Rel/NF-kß and Ikß proteins: an overview. Sem. Cancer Biol 8: 63-73, 1997.
20. Hartsough MT and Mulder KM: Transforming growth factor-ß signaling in epithelial cells. Pharmacol Ther 75: 21-41, 1997.
21. Ozbun M and Meyers C: Transforming growth factor β1 induces differentiation in human papillomavirus-positive keratinocytes. J Virol 70: 5437-46, 1996.
22. Arsura M, Fitzgerald MJ, Fausto N and Sonenshien GE: Nuclear factor-k-B Rel blocks transforming growth factor β1-induced apoptosis of murine hepatocyte cell lines. Cell Growth Diff 8: 1049-59, 1997.
23. Reed J C: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1-6, 1994.
24. Rorke EA and Jacobberger JW: Transforming growth factor-ß1 (TGFβ1) enhances apoptosis in human papillomavirus type 16-immortalized ectocervical epithelial cells. Exper Cell Res 216: 65-72, 1995.
25. Endoh M, Kashem A, Yamauchi F, Yano N, Nomoto Y, Sakai H and Kurokawa K: Expression of thromboxane synthase in kidney tissues from patients with IgA nephropathy. Clin Nephrol 47: 168-75, 1997.
26. Meyer R, Hatada E.N, Hohmann H.P, Haiker M, Bartsch C, Rothlisberger U, Lahm HW, Schlaeger EJ, van Loon AP and Scheidereit C: Cloning of the DNA-binding subunit of human nuclear factor kappa ß: the level of its mRNA is strongly regulated by phorbol ester or tumor necrosis factor alpha. Proc Natl Aca Sci USA 88: 966-70, 1991.